Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb;143(2):782-785.e1.
doi: 10.1016/j.jaci.2018.09.019. Epub 2018 Oct 9.

EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease

Affiliations
Case Reports

EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease

David C Thomas et al. J Allergy Clin Immunol. 2019 Feb.

Abstract

We demonstrate for the first time that EROS (CYBC1/C17ORF62) regulates abundance of the gp91phox-p22phox heterodimer of the phagocyte NADPH oxidase in human cells and that EROS mutations are a novel cause of chronic granulomatous disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. EROS function is conserved in humans.
(A-C) Western blot of (A) EROS (B) gp91phox (C) p22phox, (D) surface gp91phox expression and (E) phagocyte respiratory burst in CRISPR targeted PLB-985 clones (F) surface expression of gp91phox in CRISPR targeted cells +/− overexpression of EROS-GFP. (G) NBT reduction following reconstitution with EROS-GFP lentiviral vector. Representative of 3 independent experiments.
Figure 2:
Figure 2:. Homozygous EROS mutation has deleterious effects.
(A, B): respiratory burst in patient and healthy control neutrophils. (C) homozygous c.127 A to G mutation (D) EROS protein expression in CD3/CD2/CD28 expanded PBMC from patient, sister and a healthy control, control CD4+ T cells pre and post CD3/CD2/CD28 or PBMC from a further healthy control. Representative of 2–3 independent experiments.

References

    1. Segal AW. How neutrophils kill microbes. Annual review of immunology. 2005;23:197–223. - PMC - PubMed
    1. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PloS one. 2009;4(4):e5234. - PMC - PubMed
    1. Thomas DC, Clare S, Sowerby JM, Pardo M, Juss JK, Goulding DA, et al. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. The Journal of experimental medicine. 2017. - PMC - PubMed
    1. Monies D, Abouelhoda M, AlSayed M, Alhassnan Z, Alotaibi M, Kayyali H, et al. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet. 2017;136(8):921–39. - PMC - PubMed
    1. Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E Jr., et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. The Journal of allergy and clinical immunology. 2016;138(1):241–8 e3. - PubMed